this conference call does not sound like good news. price has fallen way to much for a reason (maybe an inside reason?).
However, the fact that just a few months back, ariad announced it was expanding its facilities and its employees for demand of present and future launches. That hasn't changed, right? the company is still moving forward as a fully integrated and operating oncology firm, correct?
in any case, sure Hope the "harv" doesn't show true colors, like the so many ceo's before him, and set us up for a reaming.